New Jersey Center for Cancer Research

Brick, NJ

Sorting 1 by

Not currently accepting

IBI188

A Study Evaluating the Safety and Efficacy of IBI188 in Combination With AZA in Subjects With Newly Diagnosed MDS
  • Monoclonal Antibody
  • Phase 1